{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-024676","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.895895+00:00","generated_at":"2026-05-15T18:36:09.857871+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Tvardi Therapeutics announces June 9, 2026 annual meeting; sets proposal deadlines","bullets":["Annual meeting of stockholders scheduled for June 9, 2026.","Rule 14a-8 stockholder proposals for proxy inclusion must be received by March 16, 2026.","Advance notice for director nominations and other business under bylaws due March 16, 2026.","Universal proxy rule (Rule 14a-19) notices for director nominees due April 10, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-024676","json":"https://secwatch.observer/filing/0001104659-26-024676.json","markdown":"https://secwatch.observer/filing/0001104659-26-024676.md","text":"https://secwatch.observer/filing/0001104659-26-024676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926024676/0001104659-26-024676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465926024676/tm268178d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:36:09.857871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}